Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial

Mark F CottonCHER Study Team


Interim results from the children with HIV early antiretroviral (CHER) trial showed that early antiretroviral therapy (ART) was life-saving for infants infected with HIV. In view of the few treatment options and the potential toxicity associated with lifelong ART, in the CHER trial we compared early time-limited ART with deferred ART. CHER was an open-label randomised controlled trial of HIV-infected asymptomatic infants younger than 12 weeks in two South African trial sites with a percentage of CD4-positive T lymphocytes (CD4%) of 25% or higher. 377 infants were randomly allocated to one of three groups: deferred ART (ART-Def), immediate ART for 40 weeks (ART-40W), or immediate ART for 96 weeks (ART-96W), with subsequent treatment interruption. The randomisation schedule was stratified by clinical site with permuted blocks of random sizes to balance the numbers of infants allocated to each group. Criteria for ART initiation in the ART-Def group and re-initiation after interruption in the other groups were CD4% less than 25% in infancy; otherwise, the criteria were CD4% less than 20% or Centers for Disease Control and Prevention severe stage B or stage C disease. Combination therapy of lopinavir-ritonavir, zidovudine, and lamiv...Continue Reading


Oct 7, 2004·Lancet·Marie-Louise NewellUNKNOWN Ghent International AIDS Society (IAS) Working Group on HIV Infection in Women and Children
Dec 1, 2006·The New England Journal of Medicine·UNKNOWN Strategies for Management of Antiretroviral Therapy (SMART) Study GroupC Rappoport
May 29, 2007·The Pediatric Infectious Disease Journal·Edmore MarindaUNKNOWN ZVITAMBO Study Group
Nov 21, 2008·The New England Journal of Medicine·Avy ViolariUNKNOWN CHER Study Team
Nov 3, 2009·HIV Medicine·UNKNOWN PENTA Steering CommitteeDiane Bastiaans
Dec 17, 2009·AIDS·UNKNOWN Paediatric European Network for Treatment of AIDS
Jun 30, 2010·The Journal of Infectious Diseases·Shabir A MadhiUNKNOWN Comprehensive International Program of Research on AIDS 4 Study Team
Jun 22, 2012·The New England Journal of Medicine·Avy ViolariPaul Palumbo
Jan 18, 2013·The New England Journal of Medicine·UNKNOWN SPARTAC Trial InvestigatorsAbdel Babiker
May 24, 2013·The New England Journal of Medicine·Jonathan WeberAbdel Babiker

❮ Previous
Next ❯


Nov 20, 2013·Current Opinion in HIV and AIDS·Intira J CollinsDiana M Gibb
Jun 14, 2014·Journal of the International AIDS Society·Steve InnesMark F Cotton
Jul 20, 2014·Advances in Pediatrics·Daniel GonzalezMichael Cohen-Wolkowiez
Nov 25, 2014·Journal of the International AIDS Society·Mark F Cotton, Helena Rabie
Nov 12, 2013·Lancet·Robert Colebunders, Victor Musiime
Jul 25, 2015·Expert Review of Anti-infective Therapy·Mohammad-Ali JenabianLaurent Bélec
Jan 15, 2016·The Lancet. HIV·Helena Rabie, Mark F Cotton
Mar 15, 2016·Nature Reviews. Immunology·Philip J GoulderEllen M Leitman
Nov 5, 2013·Developmental Medicine and Child Neurology·Nelleke G LangerakBarbara Laughton
May 23, 2014·The Journal of Infectious Diseases·Jonathan Z Li, Rajesh T Gandhi
Oct 2, 2015·The Lancet. HIV·Francesca CellettiJanice Soo Fern Lee
Jan 24, 2015·Archives of Disease in Childhood·Andrew J PrendergastMartina Penazzato
Sep 5, 2014·Archives of Disease in Childhood·Alasdair Bamford, Hermione Lyall
Oct 8, 2016·Current Opinion in HIV and AIDS·Mary-Ann DaviesAnna Turkova
Sep 8, 2016·AIDS·Katherine Luzuriaga, Deborah Persaud
Sep 30, 2016·Current Opinion in HIV and AIDS·Elvira SinghJulia Bohlius
Feb 11, 2014·Expert Review of Anti-infective Therapy·Stephanie Shiau, Louise Kuhn
Mar 30, 2017·PloS One·Patricia Rojas SánchezUNKNOWN Madrid Cohort of HIV-1 Infected Children and Adolescents Integrated in the Paediatric Branch of the Spanish National AIDS Ne
Jun 10, 2017·International Journal of STD & AIDS·Beatris M MartinSonia M Raboni
Nov 13, 2014·Current Opinion in HIV and AIDS·Mark F Cotton, Helena Rabie
Dec 12, 2017·The Pediatric Infectious Disease Journal·Moherndran ArcharyStefanie Hennig
Nov 15, 2017·African Journal of AIDS Research : AJAR·Patrick ShabanguNobuhle Mthethwa

❮ Previous
Next ❯

Related Concepts

Related Feeds


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.